Medical News

RSS

Fatty acids may be the culprit in Alzheimer's

According to new research from the U.S. controlling the level of a fatty acid in the brain could help treat Alzheimer's disease (AD).

21 Oct 2008

Bird flu appears again in Hong Kong

Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.

21 Oct 2008

Gene could 'knock the sox' off cancer!

Australian scientists from the Institute for Molecular Bioscience at The University of Queensland (UQ), have identified a gene which could very well 'knock the sox' off cancer and lymphatic disorders.

21 Oct 2008

New Zealand to trial pig cells as treatment for type 1 diabetes

Authorities in New Zealand have given conditional approval for a human trial to go ahead using pig cells to treat type 1 diabetes.

21 Oct 2008

FDA grants orphan drug status to new 'Trojan Horse' like Ewing's Sarcoma drug

The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ewing's Sarcoma cancer. The efforts to develop this drug were made possible by the generous volunteers and researchers in private industry and at two universities.

20 Oct 2008

Getting the flu early may protect against worse one later

New evidence about the worldwide influenza pandemic of 1918-1919 indicates that getting the flu early protected many people against a second deadlier wave, an article co-authored by an NIH epidemiologist concludes.

20 Oct 2008

People lacking essential antioxidants and sunlight more likely to develop advanced macular degeneration

People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a study published today in the journal Archives of Ophthalmology. AMD is the leading cause of poor vision in the UK.

20 Oct 2008

Teva granted FDA approval for Fentanyl transdermal system

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System, 25 mcg/hour, 50 mcg/hour, 75 mcg/hour and 100 mcg/hour, the AB-rated generic equivalent of Ortho McNeil's chronic pain treatment Duragesic. Shipment of this product has commenced.

20 Oct 2008

Link between erectile dysfunction and heart attacks

A link between erectile dysfunction and heart attacks will be made by Professor Mike Kirby at the University of Hertfordshire Health and Human Sciences Research Institute Showcase today.

20 Oct 2008

New tuberculosis test reveals patients at risk

A recently introduced blood test can reveal which patients may develop active tuberculosis (TB) much more precisely than the 100-year old TB skin test, according to a new study published today in the journal Annals of Internal Medicine.

20 Oct 2008

Contact lenses are home to pathogenic amoebae

Contact lenses increase the risk of infection with pathogenic protozoa that can cause blindness. New research, published in the November issue of the Journal of Medical Microbiology, shows that a high percentage of contact lens cases in Tenerife are contaminated with Acanthamoeba that cannot be killed by normal contact lens solution.

20 Oct 2008

Getting to grips with the complexity of disease proteins

Drug molecules seldom act simply on one protein but on protein complexes and networks. A deeper understanding of these 'cooperative assemblies' should lead to better targeting of drugs.

20 Oct 2008

Sun-damaged skin responds well to laser treatment

Researchers at the University of Michigan Health System Department of Dermatology have found scientific evidence that the appearance of sun-damaged skin may be improved by treatment with a topical product that increases the skin's sensitivity to light, followed by laser therapy.

20 Oct 2008

Targeted cell delivery to the cervical spinal cord is a promising strategy to slow loss of motor neurons in ALS

In a disease like ALS - one that's always fatal and that has a long history of research-resistant biology - finding a proof of principle in animal models is significant.

20 Oct 2008

Johns Hopkins researchers detect sweet cacophany while listening to cellular cross-talk

Johns Hopkins scientists were dubious in the early 1980s when they stumbled on small sugar molecules lurking in the centers of cells; not only were they not supposed to be there, but they certainly weren't supposed to be repeatedly attaching to and detaching from proteins, effectively switching them on and off.

20 Oct 2008

Birth control has long term effect on hormone exposure

Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.

20 Oct 2008

Beyond recognizing odors, a single neuron controls reactions

Babies will smile when they catch the scent of vanilla, but a whiff of rotting meat will send them into fits. From people to mice and flies to worms, animals of all kinds are born with likes and dislikes thanks to the evolutionary wisdom collected in their genes. But new research shows that some preferences are still surprisingly flexible at even the most basic level - that of the sensory neuron itself - and that our nervous system may be even more adaptable than we thought.

20 Oct 2008

Bristol scientist puts the brakes on breast cancer

Why do breast cells grow out of control? The answer could be a step closer thanks to a grant of around £200,000 from one of the UK's leading breast cancer research charities, Breast Cancer Campaign, to University of Bristol scientist, Dr Claire Perks.

20 Oct 2008

New guides to preventing and treating osteoporosis

Dr Maria Fiatarone Singh, geriatrician and Professor of Medicine and Exercise and Sport Science at the University of Sydney has written a series of exercise guides.

20 Oct 2008

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Genentech, Inc. today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.

20 Oct 2008